Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Devang Kantesaria currently holds 2,429,543 shares of INOTEK PHARMACEUTICALS CORP (ITEK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Devang Kantesaria has been a net buyer of ITEK stock. They have purchased $4.9M and sold $0 worth of shares.
Devang Kantesaria's most recent insider trade was on Feb 23, 2015, when they sold 105,933 shares at $0.00 per share.
Devang Kantesaria serves as Executive at INOTEK PHARMACEUTICALS CORP (ITEK). They have executed 3 insider transactions totaling $4.9M over their tenure at the company.
Devang Kantesaria holds the position of Executive at INOTEK PHARMACEUTICALS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Devang Kantesaria has shown a buying trading pattern, with $4.9M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Devang Kantesaria was on Feb 23, 2015, when they purchased $4.9M worth of ITEK shares. This transaction involved 814,166 shares at $6.00 per share.
Devang Kantesaria currently owns 2,429,543 shares of INOTEK PHARMACEUTICALS CORP (ITEK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Devang Kantesaria's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Devang Kantesaria has 3 Form 4 filings on record as an insider at INOTEK PHARMACEUTICALS CORP.
Set alerts for Devang Kantesaria and 40,000+ other insiders.